Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): First Call Analysts Project EPS 12.63 For The Current Year

The stock price of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) ended the previous session at 516.55. During the present trading session, the stock’s touched a high of 521.78 and low of 504.06. Regeneron Pharmaceuticals, Inc., a publicly traded company listed on NMS has a current market capitalisation of 52.29B. The three-month trading history of the stock shows that it has an average trading volume of 743048.

Based on technical analysis, the stock’s 50 Day Moving Average stands at 551.19. As per the stock’s current trading session, its price is -8.20% away from the 50 Day Moving Average. Further looking at the extended stock history, it is established that the equity is trading -5.94% off the 200-day average. The comparison between the stock’s current price and its 52-week high of 605.93 and 52-week low of 393.00 shows that the equity is trading -16.49% and +28.76% away from those levels respectively.

Few brokerage firms provide estimates on the earnings and future stock direction. As of now, the sell-side analysts have projected the stock’s one-year price target at 625.00. The company’s EPS during the last one year stood at 5.06. First Call analysts expect the company to report EPS of 3.57 in its next quarter. The stock’s EPS forecast for the current year stand at 12.63 while the EPS estimates for the next year is kept at 14.97.

The price to earnings ratio or P/E ratio, which compares company’s current share price with its per-share earnings, stands at 99.94. P/E ratio is considered as an important ratio as a higher ratio signifies that the investors are optimistic about the company’s future earnings growth as against similar companies within the industry that have lower P/E ratio. The brokerage firms have projected the stock’s Price to current year EPS at 40.06. Meanwhile, the Price to next year’s EPS projections sits at 33.80.

Discover Which Stocks Can Turn Every $10,000 into $42,749!

It’s a new way to trade stocks with a 91% to 100% success rate, and earn between 8% and 199% in as little as 14 days. This strategy has nothing to do with using options to short the market. In fact, you buy stocks the same way you do now… but with one simple difference.

About the Author

Leave a Reply

Your email address will not be published. Required fields are marked *

You may also like these